Abstract:Abstract Background Dengue and Chikungunya are Aedes-borne diseases that are predominantly prevalent in tropical and subtropical regions, affecting public health globally. Dengue is caused by multiple antigenically different Dengue virus (DENV) serotypes (DENV-1 to DENV-4) in the Flaviviridae family and Chikungunya (CHIKV) in the Togaviridae family. Both viral diseases can produce similar clinical manifestations, especially in the early stages of infection which poses a significant challenge for timely diagnosis and improper disease management. Currently in India, diagnosis of Dengue and Chikungunya relies on ELISA-based tests, which often lead to false negatives and under estimation of the actual disease burden. The city of Bengaluru, in the state of Karnataka, in Southern India, witnesses spike in Dengue infection, and hence it is important to diagnose these arboviral infections early as well as accurately, to estimate the disease burden for precise epidemiological assessments. Methods A multiplex, quantitative, real-time PCR assay, DENCHIK was developed that can detect and differentiate between all four DENV serotypes and CHIKV infections simultaneously. Using DENCHIK assay, a total of 903 sera samples from suspected febrile patients were screened. The blood samples were collected across 161 public health centers, maternity homes and referral hospitals, in urban Bengaluru, between July 2022 - December 2022. The sensitivity and specificity of DENCHIK assay was compared with ELISA (NS1 antigen and Immunoglobulin M (IgM) antibodies) and two commercially available q RT-PCR assays for DENV and CHIKV. Findings Using DENCHIK assay, out of 903 samples, 36% infections were DENV, 17% CHIKV infections and 8% were coinfections with DENV-CHIKV. In contrast, ELISA detected 29.90% of DENV and 22.92% of CHIKV infections. We observed 9% prevalence of DENV infections using NS1 ELISA as compared to 24% as detected by IgM ELISA. DENV-1 was the predominant serotype followed by DENV-2, DENV-3 and DENV-4. There was an increase in the prevalence of DENV and CHIKV infections from June 2022 to September 2022, coinciding with the monsoon season. However, there was no significant difference observed in the prevalence of DENV and CHIKV infections across genders and age groups. The sensitivity and specificity of DENCHIK assay in DENV detection as compared to NS1 ELISA assay was observed to be 62.82% and 66.45%, respectively. In comparison to commercially available q RT-PCR assays for DENV detection, DENCHIK assay exhibited 99% and 98% sensitivity and specificity, respectively. Similarly, in case of CHIKV 26% sensitivity, 86% specificity and 98% sensitivity and specificity were observed, as compared to the IgM ELISA and commercial RT-PCR assays, respectively. Conclusion DENCHIK assay successfully enabled, simultaneous amplification of all four DENV serotypes and Chikungunya, in a single tube from clinical samples with high sensitivity and specificity. DENCHIK assay detected 7.6% of additional Dengue infections and 6.65% less of Chikungunya infections in clinical samples, as compared to detection by ELISA. As, compared to ELISA, DENCHIK demonstrates early and accurate detection of DENV and CHIKV with higher sensitivity and specificity as early as day one of symptom onset post infection. DENCHIK aids in estimating the exact prevalence of DENV and CHIKV infections, that are often misdiagnosed or overestimated, respectively, using routine serological assays such as ELISA. Molecular surveillance using targeted diagnostic assays such as DENCHIK could be used to determine the prevalence of multiple DENV serotypes, CHIKV and DENV-CHIKV Co-infections from clinical samples. The findings from the study shall be useful to inform and aid the public health authorities, to contain and curb the rapid spread of these diseases in the community.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a cost - effective multiplex quantitative real - time PCR detection method (DENCHIK) for the early detection and monitoring of dengue (DENV) and chikungunya (CHIKV) and their co - infections, especially in resource - limited settings. Specifically, the researchers hope: 1. **Improve diagnostic accuracy**: By developing the DENCHIK multiplex qRT - PCR detection method to simultaneously detect four dengue virus serotypes (DENV - 1 to DENV - 4) and chikungunya virus (CHIKV), in order to improve the sensitivity and specificity of early diagnosis. 2. **Solve the limitations of existing detection methods**: Currently in India, the diagnosis of dengue and chikungunya mainly depends on ELISA (non - structural protein 1 antigen and immunoglobulin M antibody) tests, which often lead to false negatives and underestimation of the disease burden. The DENCHIK detection method aims to overcome these limitations and provide more accurate diagnostic results. 3. **Monitor disease prevalence**: By simultaneously detecting multiple DENV serotypes and CHIKV, as well as DENV - CHIKV co - infections in clinical samples, it helps public health departments better understand the prevalence of the disease and take timely prevention and control measures. 4. **Optimize clinical management**: Early and accurate diagnosis helps clinicians take appropriate treatment measures in a timely manner, reducing misdiagnosis and missed diagnosis, and improving the clinical management of patients. In summary, the goal of this study is to improve the early diagnosis ability of dengue and chikungunya by developing and validating the DENCHIK multiplex qRT - PCR detection method, so as to better control and manage these diseases.

Development of a cost-effective multiplex quantitative RT-PCR assay for early detection and surveillance of Dengue, Chikungunya, and co-infections from clinical samples in low-resource settings

Development of Multiplex Molecular Assays for Simultaneous Detection of Dengue Serotypes and Chikungunya Virus for Arbovirus Surveillance

Evaluation of an immunochromatography rapid diagnosis kit for detection of chikungunya virus antigen in India, a dengue-endemic country

Performance evaluation of TaqMan™ Arbovirus Triplex Kit (ZIKV/DENV/CHIKV) for detection and differentiation of Dengue and Chikungunya viral RNA in serum samples of symptomatic patients

Utilization of novel molecular multiplex methods for the detection and, epidemiological surveillance of dengue virus serotypes and chikungunya virus in Burkina Faso, West Africa

Dengue dynamics: Prognostic and disease monitoring through molecular and serological profiling of clinical isolates

Point of sampling detection of Zika virus within a multiplexed kit capable of detecting dengue and chikungunya

A rapid, specific and ultrasensitive detection of the Chikungunya virus based on RT-RPA:CRISPR/Cas12a one-pot dual mode end-point detection system

Serotype-specific detection of dengue viruses in a nonstructural protein 1-based enzyme-linked immunosorbent assay validated with a multi-national cohort

Quantitative detection of chikungunya, Zika, and dengue viruses by one-step real-time PCR in different cell substrates

Simultaneous detection and quantitation of Chikungunya, dengue and West Nile viruses by multiplex RT-PCR assays and dengue virus typing using high resolution melting

Rapid and sensitive detection of chikungunya virus using one-tube, reverse transcription, semi-nested multi-enzyme isothermal rapid amplification, and lateral flow dipstick assays

Co-distribution of dengue and Chikungunya viruses in Aedes mosquitoes of Delhi, India

Potential Performance of Two New RT-PCR and RT-qPCR Methods for Multiplex Detection of Dengue Virus Serotypes 1–4 and Chikungunya Virus in Mosquitoes

Beyond the Bite: Detailed findings on Chikungunya and Dengue co-detection in Punjab, North India - clinical insights and diagnostic challenges

Molecular identification and phylogenetic analysis of chikungunya virus among dengue-negative patients in Kolkata, India

Comparative Study of Antigen Detection and Viral Nucleic Acid Assay for Early Detection of Dengue Infection

Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue Virus Infection in a Tertiary Care Hospital in Karnataka, India

Co-circulation of Chikungunya and Dengue viruses in Dengue endemic region of New Delhi, India during 2016

Dengue and Chikungunya virus co-infection in major metropolitan cities of provinces of Punjab and Khyber Pakhtunkhwa: A multi-center study

Multiplexed kit based on Luminex technology and achievements in synthetic biology discriminates Zika, chikungunya, and dengue viruses in mosquitoes